- Home
- CLLS vs GGT Comparison
CLLS vs GGT Comparison
Compare CLLS & GGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- GGT
- Stock Information
- Founded
- CLLS 1999
- GGT 1994
- Country
- CLLS France
- GGT United States
- Employees
- CLLS N/A
- GGT N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- GGT Trusts Except Educational Religious and Charitable
- Sector
- CLLS Health Care
- GGT Finance
- Exchange
- CLLS Nasdaq
- GGT Nasdaq
- Market Cap
- CLLS 144.4M
- GGT 128.7M
- IPO Year
- CLLS 2007
- GGT N/A
- Fundamental
- Price
- CLLS $1.49
- GGT $4.09
- Analyst Decision
- CLLS Buy
- GGT
- Analyst Count
- CLLS 3
- GGT 0
- Target Price
- CLLS $6.67
- GGT N/A
- AVG Volume (30 Days)
- CLLS 46.6K
- GGT 59.7K
- Earning Date
- CLLS 05-12-2025
- GGT 01-01-0001
- Dividend Yield
- CLLS N/A
- GGT 15.56%
- EPS Growth
- CLLS N/A
- GGT N/A
- EPS
- CLLS N/A
- GGT 0.83
- Revenue
- CLLS $54,747,000.00
- GGT N/A
- Revenue This Year
- CLLS $48.52
- GGT N/A
- Revenue Next Year
- CLLS $5.17
- GGT N/A
- P/E Ratio
- CLLS N/A
- GGT $6.90
- Revenue Growth
- CLLS 351.26
- GGT N/A
- 52 Week Low
- CLLS $1.10
- GGT $4.32
- 52 Week High
- CLLS $2.78
- GGT $7.00
- Technical
- Relative Strength Index (RSI)
- CLLS 51.15
- GGT 35.76
- Support Level
- CLLS $1.46
- GGT $3.98
- Resistance Level
- CLLS $1.60
- GGT $4.16
- Average True Range (ATR)
- CLLS 0.08
- GGT 0.07
- MACD
- CLLS -0.01
- GGT -0.01
- Stochastic Oscillator
- CLLS 52.17
- GGT 26.19
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.